EdgarLookup

Avery Dennison Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Avery Dennison Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
7.8%
Profit Margin
Net income ÷ revenue
7.8%
Return on Assets
Net income ÷ assets
+1.1%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.86B Feb 25, 2026
FY2025 Dec 28, 2024 $8.76B Feb 25, 2026
FY2025 Dec 30, 2023 $8.36B Feb 25, 2026
FY2024 Dec 31, 2022 $9.04B Feb 26, 2025
FY2023 Jan 1, 2022 $8.41B Feb 21, 2024
FY2020 Jan 2, 2021 $1.99B Feb 25, 2021
FY2020 Sep 26, 2020 $1.73B Feb 25, 2021
FY2020 Jun 27, 2020 $1.53B Feb 25, 2021
FY2020 Mar 28, 2020 $1.72B Feb 25, 2021
FY2020 Dec 28, 2019 $1.77B Feb 25, 2021

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 30, 2017 $1.74B Feb 21, 2018
FY2017 Sep 30, 2017 $1.68B Feb 21, 2018
FY2017 Jul 1, 2017 $1.63B Feb 21, 2018
FY2017 Apr 1, 2017 $1.57B Feb 21, 2018
FY2017 Dec 31, 2016 $1.55B Feb 21, 2018
FY2017 Oct 1, 2016 $1.51B Feb 21, 2018
FY2017 Jul 2, 2016 $1.54B Feb 21, 2018
FY2017 Apr 2, 2016 $1.49B Feb 21, 2018
FY2016 Jan 2, 2016 $1.45B Feb 23, 2017
FY2016 Oct 3, 2015 $1.47B Feb 23, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $688.00M Feb 25, 2026
FY2025 Dec 28, 2024 $704.90M Feb 25, 2026
FY2025 Dec 30, 2023 $503.00M Feb 25, 2026
FY2024 Dec 31, 2022 $757.10M Feb 26, 2025
FY2023 Jan 1, 2022 $740.10M Feb 21, 2024
FY2022 Jan 2, 2021 $555.90M Feb 22, 2023
FY2021 Dec 28, 2019 $303.60M Feb 23, 2022
FY2020 Dec 29, 2018 $467.40M Feb 25, 2021
FY2019 Dec 30, 2017 $281.80M Feb 26, 2020
FY2018 Dec 31, 2016 $320.70M Feb 27, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.80B Feb 25, 2026
FY2025 Dec 28, 2024 $8.40B Feb 25, 2026
FY2024 Dec 30, 2023 $8.21B Feb 26, 2025
FY2023 Dec 31, 2022 $7.95B Feb 21, 2024
FY2022 Jan 1, 2022 $7.97B Feb 22, 2023
FY2021 Jan 2, 2021 $6.08B Feb 23, 2022
FY2020 Dec 28, 2019 $5.49B Feb 25, 2021
FY2019 Dec 29, 2018 $5.18B Feb 26, 2020
FY2018 Dec 30, 2017 $5.14B Feb 27, 2019
FY2017 Dec 31, 2016 $4.40B Feb 21, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.24B Feb 25, 2026
FY2025 Dec 28, 2024 $2.31B Feb 25, 2026
FY2025 Dec 30, 2023 $2.13B Feb 25, 2026
FY2025 Dec 31, 2022 $2.03B Feb 25, 2026
FY2024 Jan 1, 2022 $1.92B Feb 26, 2025
FY2023 Jan 2, 2021 $1.48B Feb 21, 2024
FY2022 Dec 28, 2019 $1.20B Feb 22, 2023
FY2021 Dec 29, 2018 $955.10M Feb 23, 2022
FY2019 Dec 31, 2017 $1.03B Feb 26, 2020
FY2020 Dec 30, 2017 $1.03B Feb 25, 2021

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 8 Feb 25, 2026
FY2025 Dec 28, 2024 8 Feb 25, 2026
FY2025 Dec 30, 2023 6 Feb 25, 2026
FY2024 Dec 31, 2022 9 Feb 26, 2025
FY2023 Jan 1, 2022 8 Feb 21, 2024
FY2020 Jan 2, 2021 2 Feb 25, 2021
FY2020 Sep 26, 2020 1 Feb 25, 2021
FY2020 Jun 27, 2020 0 Feb 25, 2021
FY2020 Mar 28, 2020 1 Feb 25, 2021
FY2020 Dec 28, 2019 1 Feb 25, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 8 Feb 25, 2026
FY2025 Dec 28, 2024 8 Feb 25, 2026
FY2025 Dec 30, 2023 6 Feb 25, 2026
FY2024 Dec 31, 2022 9 Feb 26, 2025
FY2023 Jan 1, 2022 8 Feb 21, 2024
FY2020 Jan 2, 2021 2 Feb 25, 2021
FY2020 Sep 26, 2020 1 Feb 25, 2021
FY2020 Jun 27, 2020 0 Feb 25, 2021
FY2020 Mar 28, 2020 1 Feb 25, 2021
FY2020 Dec 28, 2019 1 Feb 25, 2021

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $202.80M Feb 25, 2026
FY2025 Dec 28, 2024 $329.10M Feb 25, 2026
FY2024 Dec 30, 2023 $215.00M Feb 26, 2025
FY2023 Dec 31, 2022 $167.20M Feb 21, 2024
FY2022 Jan 1, 2022 $162.70M Feb 22, 2023
FY2021 Jan 2, 2021 $252.30M Feb 23, 2022
FY2021 Dec 28, 2019 $253.70M Feb 23, 2022
FY2021 Dec 29, 2018 $232.00M Feb 23, 2022
FY2020 Dec 30, 2017 $224.40M Feb 25, 2021
FY2018 Dec 31, 2016 $195.10M Feb 27, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.20B Feb 25, 2026
FY2025 Dec 28, 2024 $2.55B Feb 25, 2026
FY2024 Dec 30, 2023 $2.62B Feb 26, 2025
FY2023 Dec 31, 2022 $2.50B Feb 21, 2024
FY2022 Jan 1, 2022 $2.77B Feb 22, 2023
FY2021 Jan 2, 2021 $2.03B Feb 23, 2022
FY2020 Dec 28, 2019 $1.48B Feb 25, 2021
FY2019 Dec 29, 2018 $1.75B Feb 26, 2020